[{"Assets_0_Q2_USD":20549780.0,"CommonStockSharesOutstanding_0_Q2_shares":48173241.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-8491627.0,"NetIncomeLoss_1_Q2_USD":-8007894.0,"NetIncomeLoss_2_Q2_USD":-15341307.0,"StockholdersEquity_0_Q2_USD":14179176.0,"Ticker":"AVXL","CIK":"1314052","name":"ANAVEX LIFE SCIENCES CORP.","OfficialName":"Anavex Life Sciences Corp. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"825317693.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20190509"}]